Y, L., RJ, W., SW, L., C, F., P, C., S, L., & RL, B. (2026). Study of risk assessment scores as surrogate endpoints in pulmonary arterial hypertension trials. American journal of respiratory and critical care medicine, 212(3), 616. https://doi.org/10.1093/ajrccm/aamaf003
Chicago Style (17th ed.) CitationY, Liu, White RJ, Lee SW, Fauvel C, Correa-Jaque P, Lin S, and Benza RL. "Study of Risk Assessment Scores as Surrogate Endpoints in Pulmonary Arterial Hypertension Trials." American Journal of Respiratory and Critical Care Medicine 212, no. 3 (2026): 616. https://doi.org/10.1093/ajrccm/aamaf003.
MLA (9th ed.) CitationY, Liu, et al. "Study of Risk Assessment Scores as Surrogate Endpoints in Pulmonary Arterial Hypertension Trials." American Journal of Respiratory and Critical Care Medicine, vol. 212, no. 3, 2026, p. 616, https://doi.org/10.1093/ajrccm/aamaf003.